Related references
Note: Only part of the references are listed.MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
X-X He et al.
ONCOGENE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer
Ben-Jiang Qian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer
Angela B. Y. Hui et al.
CLINICAL CANCER RESEARCH (2011)
Increased RNA-Induced Silencing Complex (RISC) Activity Contributes to Hepatocellular Carcinoma
Byoung Kwon Yoo et al.
HEPATOLOGY (2011)
Identification of Staphylococcal Nuclease Domain-containing 1 (SND1) as a Metadherin-interacting Protein with Metastasis-promoting Functions
Mario Andres Blanco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus
I-Ju Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC)
Nijiro Nohata et al.
JOURNAL OF HUMAN GENETICS (2011)
Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion
Liping Liu et al.
CANCER RESEARCH (2010)
Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKε
Rita Moreno et al.
NUCLEIC ACIDS RESEARCH (2010)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
LYRIC/AEG-1 Is Targeted to Different Subcellular Compartments by Ubiquitinylation and Intrinsic Nuclear Localization Signals
Hayley J. Thirkettle et al.
CLINICAL CANCER RESEARCH (2009)
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Xin Lu et al.
GENES & DEVELOPMENT (2009)
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer
Libing Song et al.
JOURNAL OF PATHOLOGY (2009)
Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1
J. Li et al.
ONCOGENE (2009)
Molecular basis of nuclear Factor-κB activation by astrocyte elevated gene-1
Devanand Sarkar et al.
CANCER RESEARCH (2008)
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival
Jun Li et al.
CLINICAL CANCER RESEARCH (2008)
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
S-G Lee et al.
ONCOGENE (2008)
被撤回的出版物: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity (Retracted article. See vol. 41, pg. 4981, 2022)
N. Kikuno et al.
ONCOGENE (2007)
Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas
Michalis V. Karamouzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gaorav P. Gupta et al.
NATURE (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Activation of the nuclear factor κB pathway by astrocyte elevated gene-1:: Implications for tumor progression and metastasis
L Emdad et al.
CANCER RESEARCH (2006)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Nuclear Factor-κB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-κB-dependent transcription in cancer cells
WC Ho et al.
CANCER RESEARCH (2005)
Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer
M Langenskiöld et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65
AM O'Mahony et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
DM Brown et al.
CANCER CELL (2004)
Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription
H Buss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1
J Bohuslav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions
A Maldonado et al.
IMMUNOLOGY (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
The NF-κB activation in lymphotoxin β receptor signaling depends on the phosphorylation of p65 at serine 536
X Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of NAP1, a regulatory subunit of I kappa B kinase-related kinases that potentiates NF-kappa B signaling
F Fujita et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Pro-collagenase-1 (matrix metalloproteinase-1) binds the α2β1 integrin upon release from keratinocytes migrating on type I collagen
JA Dumin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging
EA Baker et al.
BRITISH JOURNAL OF SURGERY (2000)
Share Paper
